Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of N-acetylcysteine on hsCRP in peritoneal dialysis patients
IRCT2014063017380N2Phase 2Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Feb 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetylcysteine in chronic kidney disease (CKD) and end-stage kidney disease (ESKD), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoint: Change in hsCRP level. Started Feb 2013; status: completed.
02
Drugs
acetylcysteine
03
Conditions
chronic kidney disease (CKD)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on IRCT2014063017380N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014063017380N2.